Harmony Biosciences Holdings, Inc. (HRMY) Cash Flow Statement
Harmony Biosciences Holdings, Inc. (HRMY) generated $355.1M of operating cash flow over the twelve months to 2026-06-30, spent $178000 on capital expenditure and had free cash flow of $354.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HRMYHarmony Biosciences Holdings, Inc.Follow HRMY — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- 11.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.00 | 0.10 | 0.14 | 0.22 | 0.22 | 0.35 | 0.36 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | -0.00 | 0.10 | 0.14 | 0.22 | 0.22 | 0.35 | 0.35 | |
| Share repurchases | 0.00 | — | — | 0.10 | — | — | — | |
| Stock-based compensation | 0.00 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | — |
USD billions · SEC XBRL
Harmony Biosciences Holdings, Inc. — questions
- What is Harmony Biosciences Holdings, Inc.'s operating cash flow?
- $355.1M over the twelve months to 2026-06-30.
- How much does Harmony Biosciences Holdings, Inc. spend on capital expenditure?
- $178000 over the twelve months to 2026-06-30.
- What is Harmony Biosciences Holdings, Inc.'s free cash flow?
- $354.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Harmony Biosciences Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.